Inotiv, Inc. (NOTV)
USD 2.03
(2.53%)
USD 2.03
(2.53%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 399.4 Million USD | 12.34% |
| 2022 | 355.53 Million USD | 121.1% |
| 2021 | 160.8 Million USD | 623.88% |
| 2020 | 22.21 Million USD | 61.1% |
| 2019 | 13.78 Million USD | 60.65% |
| 2018 | 8.58 Million USD | 103.05% |
| 2017 | 4.22 Million USD | 2034.85% |
| 2016 | 198 Thousand USD | -94.7% |
| 2015 | 3.73 Million USD | -21.39% |
| 2014 | 4.75 Million USD | -7.08% |
| 2013 | 5.11 Million USD | -14.77% |
| 2012 | 5.99 Million USD | -13.24% |
| 2011 | 6.91 Million USD | -2.63% |
| 2010 | 7.1 Million USD | -20.96% |
| 2009 | 8.98 Million USD | -11.57% |
| 2008 | 10.15 Million USD | 12.88% |
| 2007 | 8.99 Million USD | -37.12% |
| 2006 | 14.31 Million USD | 0.68% |
| 2005 | 14.21 Million USD | 0.38% |
| 2004 | 14.16 Million USD | 2.52% |
| 2003 | 13.81 Million USD | 325.38% |
| 2002 | 3.24 Million USD | 3.28% |
| 2001 | 3.14 Million USD | -13.59% |
| 2000 | 3.63 Million USD | -11.26% |
| 1999 | 4.1 Million USD | 272.73% |
| 1998 | 1.1 Million USD | -78.0% |
| 1997 | 5 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 370.93 Million USD | 0.31% |
| 2024 Q3 | 3.89 Million USD | 1317.09% |
| 2024 Q2 | 275 Thousand USD | -99.93% |
| 2023 FY | 399.4 Million USD | 12.34% |
| 2023 Q4 | 399.4 Million USD | -1.03% |
| 2023 Q3 | 403.54 Million USD | 0.19% |
| 2023 Q2 | 402.77 Million USD | 2.78% |
| 2023 Q1 | 391.88 Million USD | 10.22% |
| 2022 Q1 | 274.13 Million USD | 70.48% |
| 2022 Q3 | 356.67 Million USD | 1.65% |
| 2022 Q4 | 355.53 Million USD | -0.32% |
| 2022 FY | 355.53 Million USD | 121.1% |
| 2022 Q2 | 350.88 Million USD | 28.0% |
| 2021 Q4 | 160.8 Million USD | 351.4% |
| 2021 FY | 160.8 Million USD | 623.88% |
| 2021 Q3 | 35.62 Million USD | 67.68% |
| 2021 Q2 | 21.24 Million USD | 3.1% |
| 2021 Q1 | 20.6 Million USD | -7.24% |
| 2020 Q3 | 24.91 Million USD | 10.22% |
| 2020 Q1 | 22.86 Million USD | 65.82% |
| 2020 Q2 | 22.6 Million USD | -1.13% |
| 2020 Q4 | 22.21 Million USD | -10.85% |
| 2020 FY | 22.21 Million USD | 61.1% |
| 2019 FY | 13.78 Million USD | 60.65% |
| 2019 Q4 | 13.78 Million USD | 12.27% |
| 2019 Q3 | 12.28 Million USD | 32.16% |
| 2019 Q2 | 9.29 Million USD | 11.4% |
| 2019 Q1 | 8.34 Million USD | -2.81% |
| 2018 Q4 | 8.58 Million USD | 114.84% |
| 2018 FY | 8.58 Million USD | 103.05% |
| 2018 Q3 | 3.99 Million USD | -1.38% |
| 2018 Q2 | 4.05 Million USD | -2.15% |
| 2018 Q1 | 4.14 Million USD | -2.06% |
| 2017 Q2 | 134 Thousand USD | -19.28% |
| 2017 FY | 4.22 Million USD | 2034.85% |
| 2017 Q1 | 166 Thousand USD | -16.16% |
| 2017 Q3 | 4.3 Million USD | 3115.67% |
| 2017 Q4 | 4.22 Million USD | -1.9% |
| 2016 Q2 | 53 Thousand USD | -8.62% |
| 2016 Q1 | 58 Thousand USD | -98.45% |
| 2016 Q4 | 198 Thousand USD | -14.66% |
| 2016 FY | 198 Thousand USD | -94.7% |
| 2016 Q3 | 232 Thousand USD | 337.74% |
| 2015 Q2 | 4.22 Million USD | -5.84% |
| 2015 Q4 | 3.73 Million USD | -5.8% |
| 2015 Q1 | 4.48 Million USD | -5.52% |
| 2015 Q3 | 3.96 Million USD | -6.2% |
| 2015 FY | 3.73 Million USD | -21.39% |
| 2014 Q2 | 331 Thousand USD | -17.46% |
| 2014 Q3 | 5.01 Million USD | 1414.2% |
| 2014 Q4 | 4.75 Million USD | -5.23% |
| 2014 Q1 | 401 Thousand USD | -92.16% |
| 2014 FY | 4.75 Million USD | -7.08% |
| 2013 Q4 | 5.11 Million USD | 846.67% |
| 2013 FY | 5.11 Million USD | -14.77% |
| 2013 Q3 | 540 Thousand USD | -11.04% |
| 2013 Q2 | 607 Thousand USD | -11.9% |
| 2013 Q1 | 689 Thousand USD | -88.51% |
| 2012 Q2 | 1.05 Million USD | -5.99% |
| 2012 Q4 | 5.99 Million USD | 464.78% |
| 2012 Q3 | 1.06 Million USD | 1.05% |
| 2012 FY | 5.99 Million USD | -13.24% |
| 2012 Q1 | 1.11 Million USD | -83.83% |
| 2011 Q4 | 6.91 Million USD | -5.25% |
| 2011 Q1 | 6.76 Million USD | -4.72% |
| 2011 Q2 | 6.59 Million USD | -2.51% |
| 2011 Q3 | 7.29 Million USD | 10.63% |
| 2011 FY | 6.91 Million USD | -2.63% |
| 2010 Q3 | 6.2 Million USD | -5.53% |
| 2010 FY | 7.1 Million USD | -20.96% |
| 2010 Q2 | 6.56 Million USD | -14.22% |
| 2010 Q1 | 7.65 Million USD | -14.81% |
| 2010 Q4 | 7.1 Million USD | 14.48% |
| 2009 Q4 | 8.98 Million USD | -2.94% |
| 2009 Q2 | 9.53 Million USD | -3.13% |
| 2009 FY | 8.98 Million USD | -11.57% |
| 2009 Q1 | 9.83 Million USD | -3.15% |
| 2009 Q3 | 9.25 Million USD | -2.89% |
| 2008 Q2 | 10.48 Million USD | 0.83% |
| 2008 FY | 10.15 Million USD | 12.88% |
| 2008 Q1 | 10.39 Million USD | 15.5% |
| 2008 Q3 | 10.46 Million USD | -0.11% |
| 2008 Q4 | 10.15 Million USD | -2.96% |
| 2007 Q2 | 9.39 Million USD | -31.0% |
| 2007 Q4 | 8.99 Million USD | -2.38% |
| 2007 Q3 | 9.21 Million USD | -1.88% |
| 2007 FY | 8.99 Million USD | -37.12% |
| 2007 Q1 | 13.61 Million USD | -4.86% |
| 2006 Q3 | 14.5 Million USD | 2.87% |
| 2006 Q4 | 14.31 Million USD | -1.31% |
| 2006 Q1 | 14.24 Million USD | 0.2% |
| 2006 Q2 | 14.09 Million USD | -1.03% |
| 2006 FY | 14.31 Million USD | 0.68% |
| 2005 Q4 | 14.21 Million USD | -0.86% |
| 2005 Q2 | 14.31 Million USD | 4.47% |
| 2005 Q1 | 13.69 Million USD | -3.26% |
| 2005 Q3 | 14.33 Million USD | 0.2% |
| 2005 FY | 14.21 Million USD | 0.38% |
| 2004 Q3 | 14.33 Million USD | -0.35% |
| 2004 FY | 14.16 Million USD | 2.52% |
| 2004 Q4 | 14.16 Million USD | -1.24% |
| 2004 Q1 | 14.51 Million USD | 5.1% |
| 2004 Q2 | 14.38 Million USD | -0.88% |
| 2003 Q1 | 9.63 Million USD | 196.82% |
| 2003 Q4 | 13.81 Million USD | 2.3% |
| 2003 FY | 13.81 Million USD | 325.38% |
| 2003 Q3 | 13.5 Million USD | 35.18% |
| 2003 Q2 | 9.98 Million USD | 3.63% |
| 2002 Q1 | 3.02 Million USD | -3.88% |
| 2002 Q3 | 3.42 Million USD | 18.05% |
| 2002 Q4 | 3.24 Million USD | -5.08% |
| 2002 FY | 3.24 Million USD | 3.28% |
| 2002 Q2 | 2.89 Million USD | -4.1% |
| 2001 Q1 | 3.52 Million USD | -3.2% |
| 2001 Q4 | 3.14 Million USD | -4.29% |
| 2001 FY | 3.14 Million USD | -13.59% |
| 2001 Q2 | 3.4 Million USD | -3.35% |
| 2001 Q3 | 3.28 Million USD | -3.5% |
| 2000 Q1 | 4.1 Million USD | 0.0% |
| 2000 Q2 | 3.88 Million USD | -5.2% |
| 2000 Q3 | 3.77 Million USD | -2.93% |
| 2000 Q4 | 3.63 Million USD | -3.57% |
| 2000 FY | 3.63 Million USD | -11.26% |
| 1999 Q3 | 4.2 Million USD | 320.0% |
| 1999 Q4 | 4.1 Million USD | -2.38% |
| 1999 FY | 4.1 Million USD | 272.73% |
| 1999 Q1 | 1.1 Million USD | 0.0% |
| 1999 Q2 | 1 Million USD | -9.09% |
| 1998 Q3 | - USD | -100.0% |
| 1998 FY | 1.1 Million USD | -78.0% |
| 1998 Q2 | 100 Thousand USD | -66.67% |
| 1998 Q1 | 300 Thousand USD | -94.06% |
| 1998 Q4 | 1.1 Million USD | 0.0% |
| 1997 FY | 5 Million USD | 0.0% |
| 1997 Q4 | 5.05 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 3.07 Million USD | -12893.136% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -53935.381% |
| Aspira Women's Health Inc. | 1.43 Million USD | -27830.699% |
| Biodesix, Inc. | 35.22 Million USD | -1033.879% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -404311.571% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -35610.365% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -35610.365% |
| Bionano Genomics, Inc. | 7.17 Million USD | -5466.676% |
| CareDx, Inc | 28.27 Million USD | -1312.437% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 14.19 Million USD | -2713.136% |
| DarioHealth Corp. | 24.59 Million USD | -1524.208% |
| Exact Sciences Corporation | 2.47 Billion USD | 83.865% |
| Fulgent Genetics, Inc. | 10.11 Million USD | -3850.242% |
| Guardant Health, Inc. | 1.13 Billion USD | 64.963% |
| ICON Public Limited Company | 3.66 Billion USD | 89.103% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 35.877% |
| Illumina, Inc. | 1.48 Billion USD | 73.176% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -491032.999% |
| iSpecimen Inc. | 29.13 Thousand USD | -1371025.987% |
| Standard BioTools Inc. | 3.98 Million USD | -9927.843% |
| MDxHealth SA | 35.56 Million USD | -1023.071% |
| 23andMe Holding Co. | 67.84 Million USD | -488.708% |
| Medpace Holdings, Inc. | 142.12 Million USD | -181.032% |
| Myriad Genetics, Inc. | 130.9 Million USD | -205.125% |
| Mainz Biomed B.V. | 2.19 Million USD | -18088.943% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -207858.368% |
| NeoGenomics, Inc. | 606.06 Million USD | 34.098% |
| Neogen Corporation | 888.39 Million USD | 55.041% |
| Natera, Inc. | 282.94 Million USD | -41.161% |
| OPKO Health, Inc. | 222.03 Million USD | -79.886% |
| Psychemedics Corporation | 945 Thousand USD | -42165.503% |
| Prenetics Global Limited | 867.21 Thousand USD | -45956.514% |
| Prenetics Global Limited | 867.21 Thousand USD | -45956.514% |
| Precipio, Inc. | 106 Thousand USD | -376700.943% |
| Personalis, Inc. | 1.23 Million USD | -32267.018% |
| RadNet, Inc. | 812.06 Million USD | 50.816% |
| Sera Prognostics, Inc. | 840 Thousand USD | -47448.69% |
| Sotera Health Company | 2.22 Billion USD | 82.038% |
| Neuronetics, Inc. | 59.28 Million USD | -573.733% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -34782.882% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -34782.882% |
| Trinity Biotech plc | 54.65 Million USD | -630.836% |
| Twist Bioscience Corporation | 79.17 Million USD | -404.476% |
| Exagen Inc. | 19.23 Million USD | -1976.902% |